Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer

Yu Peng Liu, Wen Chi Liao, Luo Ping Ger, Jiun Chin Chen, Tai I. Hsu, Yu Cheng Lee, Hong Tai Chang, Yu Chia Chen, Yi Hua Jan, Kuen Haur Lee, Yu Hao Zeng, Michael Hsiao, Pei Jung Lu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Akt activation has been implicated broadly in tumorigenesis, but the basis for its dysregulation in cancer cells is incompletely understood. In this study, we sought to clarify a regulatory role for the Akt-binding carboxy-terminal modulator protein (CTMP), which has been controversial. In evaluating CTMP expression in paired normaltumor specimens of 198 patients with breast cancer, we found that CTMP was upregulated in breast tumors, where it was associated with poor patient survival. Notably, CTMP expression also correlated positively with Akt phosphorylation in breast cancer clinical specimens and cell lines. Furthermore, ectopic expression of CTMP promoted cell proliferation and enhanced the tumorigenic properties of estrogen-dependent breast cancer cells. This effect was correlated with increased sensitivity to insulin-induced Akt phosphorylation, which is mediated primarily by the phosphoinositide 3-kinase-Akt pathway. In contrast, short hairpin RNA-mediated silencing of endogenous CTMP decreased the proliferation of estrogen-dependent or estrogen-independent breast cancer cells. Mechanistic investigations defined the N-terminal domain of CTMP at amino acids 1 to 64 as responsible for Akt binding. Taken together, our results firmly corroborate the concept that CTMP promotes Akt phosphorylation and functions as an oncogenic molecule in breast cancer.

Original languageEnglish
Pages (from-to)6194-6205
Number of pages12
JournalCancer Research
Volume73
Issue number20
DOIs
Publication statusPublished - Oct 15 2013

Fingerprint

Phosphorylation
Breast Neoplasms
Proteins
Estrogens
1-Phosphatidylinositol 4-Kinase
RNA Interference
Small Interfering RNA
Insulin Resistance
Carcinogenesis
Cell Proliferation
Amino Acids
Cell Line
Survival
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer. / Liu, Yu Peng; Liao, Wen Chi; Ger, Luo Ping; Chen, Jiun Chin; Hsu, Tai I.; Lee, Yu Cheng; Chang, Hong Tai; Chen, Yu Chia; Jan, Yi Hua; Lee, Kuen Haur; Zeng, Yu Hao; Hsiao, Michael; Lu, Pei Jung.

In: Cancer Research, Vol. 73, No. 20, 15.10.2013, p. 6194-6205.

Research output: Contribution to journalArticle

Liu, YP, Liao, WC, Ger, LP, Chen, JC, Hsu, TI, Lee, YC, Chang, HT, Chen, YC, Jan, YH, Lee, KH, Zeng, YH, Hsiao, M & Lu, PJ 2013, 'Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer', Cancer Research, vol. 73, no. 20, pp. 6194-6205. https://doi.org/10.1158/0008-5472.CAN-13-0518
Liu, Yu Peng ; Liao, Wen Chi ; Ger, Luo Ping ; Chen, Jiun Chin ; Hsu, Tai I. ; Lee, Yu Cheng ; Chang, Hong Tai ; Chen, Yu Chia ; Jan, Yi Hua ; Lee, Kuen Haur ; Zeng, Yu Hao ; Hsiao, Michael ; Lu, Pei Jung. / Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer. In: Cancer Research. 2013 ; Vol. 73, No. 20. pp. 6194-6205.
@article{304b6edb9529439e867ae7f11ae517af,
title = "Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer",
abstract = "Akt activation has been implicated broadly in tumorigenesis, but the basis for its dysregulation in cancer cells is incompletely understood. In this study, we sought to clarify a regulatory role for the Akt-binding carboxy-terminal modulator protein (CTMP), which has been controversial. In evaluating CTMP expression in paired normaltumor specimens of 198 patients with breast cancer, we found that CTMP was upregulated in breast tumors, where it was associated with poor patient survival. Notably, CTMP expression also correlated positively with Akt phosphorylation in breast cancer clinical specimens and cell lines. Furthermore, ectopic expression of CTMP promoted cell proliferation and enhanced the tumorigenic properties of estrogen-dependent breast cancer cells. This effect was correlated with increased sensitivity to insulin-induced Akt phosphorylation, which is mediated primarily by the phosphoinositide 3-kinase-Akt pathway. In contrast, short hairpin RNA-mediated silencing of endogenous CTMP decreased the proliferation of estrogen-dependent or estrogen-independent breast cancer cells. Mechanistic investigations defined the N-terminal domain of CTMP at amino acids 1 to 64 as responsible for Akt binding. Taken together, our results firmly corroborate the concept that CTMP promotes Akt phosphorylation and functions as an oncogenic molecule in breast cancer.",
author = "Liu, {Yu Peng} and Liao, {Wen Chi} and Ger, {Luo Ping} and Chen, {Jiun Chin} and Hsu, {Tai I.} and Lee, {Yu Cheng} and Chang, {Hong Tai} and Chen, {Yu Chia} and Jan, {Yi Hua} and Lee, {Kuen Haur} and Zeng, {Yu Hao} and Michael Hsiao and Lu, {Pei Jung}",
year = "2013",
month = "10",
day = "15",
doi = "10.1158/0008-5472.CAN-13-0518",
language = "English",
volume = "73",
pages = "6194--6205",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer

AU - Liu, Yu Peng

AU - Liao, Wen Chi

AU - Ger, Luo Ping

AU - Chen, Jiun Chin

AU - Hsu, Tai I.

AU - Lee, Yu Cheng

AU - Chang, Hong Tai

AU - Chen, Yu Chia

AU - Jan, Yi Hua

AU - Lee, Kuen Haur

AU - Zeng, Yu Hao

AU - Hsiao, Michael

AU - Lu, Pei Jung

PY - 2013/10/15

Y1 - 2013/10/15

N2 - Akt activation has been implicated broadly in tumorigenesis, but the basis for its dysregulation in cancer cells is incompletely understood. In this study, we sought to clarify a regulatory role for the Akt-binding carboxy-terminal modulator protein (CTMP), which has been controversial. In evaluating CTMP expression in paired normaltumor specimens of 198 patients with breast cancer, we found that CTMP was upregulated in breast tumors, where it was associated with poor patient survival. Notably, CTMP expression also correlated positively with Akt phosphorylation in breast cancer clinical specimens and cell lines. Furthermore, ectopic expression of CTMP promoted cell proliferation and enhanced the tumorigenic properties of estrogen-dependent breast cancer cells. This effect was correlated with increased sensitivity to insulin-induced Akt phosphorylation, which is mediated primarily by the phosphoinositide 3-kinase-Akt pathway. In contrast, short hairpin RNA-mediated silencing of endogenous CTMP decreased the proliferation of estrogen-dependent or estrogen-independent breast cancer cells. Mechanistic investigations defined the N-terminal domain of CTMP at amino acids 1 to 64 as responsible for Akt binding. Taken together, our results firmly corroborate the concept that CTMP promotes Akt phosphorylation and functions as an oncogenic molecule in breast cancer.

AB - Akt activation has been implicated broadly in tumorigenesis, but the basis for its dysregulation in cancer cells is incompletely understood. In this study, we sought to clarify a regulatory role for the Akt-binding carboxy-terminal modulator protein (CTMP), which has been controversial. In evaluating CTMP expression in paired normaltumor specimens of 198 patients with breast cancer, we found that CTMP was upregulated in breast tumors, where it was associated with poor patient survival. Notably, CTMP expression also correlated positively with Akt phosphorylation in breast cancer clinical specimens and cell lines. Furthermore, ectopic expression of CTMP promoted cell proliferation and enhanced the tumorigenic properties of estrogen-dependent breast cancer cells. This effect was correlated with increased sensitivity to insulin-induced Akt phosphorylation, which is mediated primarily by the phosphoinositide 3-kinase-Akt pathway. In contrast, short hairpin RNA-mediated silencing of endogenous CTMP decreased the proliferation of estrogen-dependent or estrogen-independent breast cancer cells. Mechanistic investigations defined the N-terminal domain of CTMP at amino acids 1 to 64 as responsible for Akt binding. Taken together, our results firmly corroborate the concept that CTMP promotes Akt phosphorylation and functions as an oncogenic molecule in breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84885977751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885977751&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-0518

DO - 10.1158/0008-5472.CAN-13-0518

M3 - Article

C2 - 23943800

AN - SCOPUS:84885977751

VL - 73

SP - 6194

EP - 6205

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 20

ER -